Sigyn Therapeutics Discloses DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES Patent Submission and Related ImmunePrepTM Trademark Application

SAN DIEGO, CA – (NewMediaWire) – May 17, 2023 – Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, disclosed today that it has submitted a provisional patent application entitled: “DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES” to the United States Patent and Trademark…Read More